Sol-Gel Technologies Ltd.

US$61.01As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:SLGLHealthcare
Country USA
PE (Fwd) •••
TSR 9Y CAGR (6.35%)
Div yield —
ROE (40.85%)
Biotechnology
Beta (5Y) 1.24
PE TTM —
TSR TTM 76.84%
Mkt cap US$199.7M
ROIC (26.67%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$72
18.50%
80.99%
Buy 10|10|5|0|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
1.35
1.50
1.58
1.67
17.71%
35.14%
46.97%
38.39%
Revenue$M
18.92
18.48
19.12
19.77
6.54%
7.05%
4.98%
7.44%
Peers (US$199.7M)
Cap (US$)
PE
203.6M
—
185.7M
5.250x
124.7M
—
200.2M
—
Capital
TTM
5Y
10Y
Leveragex
0.451
(0.119)
(0.083)
EBIT/Intx
2.186
0.073
0.081
Own earn%
(1.06)
18.06
10.91
Sh yield%
20.69
35.39
33.21
Owners
Insiders/Inst%
1.96
77.76
Short interest%
1.02
SBC / revenue%
3.38
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
27–36
$1 testx
—
Incr. ROIC%
8